Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of Cancer
1000-467X
2012 Issue 11
Chemical proteomics:terra incognita for novel drug target profiling
Fuqiang Huang1*;Boya Zhang1*;Shengtao Zhou2;Xia Zhao2;Ce Bian2 and Yuquan Wei1 1The State Key Laboratory of Biotherapy; West ChinaHospital; Sichuan University; Chengdu; Sichuan 610041; P. R. China;2Department of Gynecology and Obstetrics; West China Second Hospital;Sichuan University; Chengdu; Sichuan 610041; P. R. China.
..............page:507-518
Solid neuroendocrine breast carcinoma:mammographic and sonographic features in thirteen cases
Jing Wu1;2;Qiu-Xia Yang1;2;Yao-Pan Wu1;2;De-Ling Wang1;2;Xue-Wen Liu1;2;Chun-Yan Cui1;2;Ling Wang1;2;Yao Chen1;3;Chuan-Miao Xie1;2 and Rong Zhang1;2 1State Key Laboratory of Oncology in South China;Guangzhou; Guangdong 510060; P. R. China;2Medical Imaging andMinimally Invasive Interventional Center;3Ultrasonic Department; Sun Yat-sen University Cancer Center; Guangzhou; Guangdong 510060; P. R.China.
..............page:549-556
Information for Authors
..............page:557
Repressing malic enzyme 1 redirects glucose metabolism,unbalances the redox state,and attenuates migratory and invasive abilities in nasopharyngeal carcinoma cell lines
Fang-Jing Zheng1;2;Hao-Bin Ye1;2;4;Man-Si Wu1;2;Yi-Fan Lian1;2;Chao-Nan Qian1;2;3 and Yi-Xin Zeng1;2 1State Key Laboratory of Oncology in South China;Guangzhou; Guangdong 510060; P. R. China;2Department of ExperimentalResearch;3Department of Nasopharyngeal Carcinoma; Sun Yat-senUniversity Cancer Center; Guangzhou; Guangdong 510060; P. R. China;4Department of Pathology; University of Rochester Medical Center;Rochester; NY; USA.
..............page:519-531
Efficacy of peripheral blood stem cell transplantation versus conventional chemotherapy on anaplastic large-cell lymphoma:a retrospective study of 64 patients from a single center
Xiao-Hui He1*;Bo Li1*;Shuang-Mei Zou2;Mei Dong1;Sheng-Yu Zhou1;Jian-Liang Yang1;Li-Yan Xue2;Sheng Yang1;Peng Liu1;Yan Qin1;Chang-Gong Zhang1;Xiao-Hong Han1 and Yuan-Kai Shi1 1Department of Medical Oncology;2Department ofPathology; Cancer Institute and Hospital; Chinese Academy of MedicalSciences and Peking Union Medical College; Beijing 100021; P. R. China.
..............page:532-540
SPARC expression and prognostic value in non-small cell lung cancer
Yan Huang1;2;*;Jing Zhang1;2;*;Yuan-Yuan Zhao1;2;Wei Jiang3;Cong Xue1;2;Fei Xu1;2;Hong-Yun Zhao4;Yang Zhang4;Li-Ping Zhao1;2;Zhi-Huang Hu1;2;Zhi-Wen Yao5;Qian-Yong Liu5 and Li Zhang1;2;4 1State Key Laboratory of Oncology in South China;Guangzhou; Guangdong 510060; P. R. China;2Department of MedicalOncology; Sun Yat-sen University Cancer Center; Guangzhou;Guangdong 510060; P. R. China;3Department of Medical Oncology;Cancer Hospital of Guangxi Medical University & Guangxi AutonomousRegional Cancer Hospital; Nanning; Guangxi 530021; P. R. China;4National Anti-Cancer Drug Clinical Research Center; Sun Yat-senUniversity Cancer Center; Guangzhou; Guangdong 510060; P. R.China;5Abraxis BioScience; Inc.; Los Angeles; CA 90025; USA.
..............page:541-548
The USCACA hosted symposiums at the 7th CACA annual meeting and the 15th CSCO annual meeting in Beijing
Michael Shi1;Wancai Yang2;3;Pascal Qian4 and Li Yan5 1Novartis Oncology; One Health Plaza; East Hanover;NJ 07936; USA;2Department of Pathology; Xinxiang Medical University;Xinxiang; Henan 453003; P. R. China;3Department of Pathology; Universityof Illinois at Chicago; IL 60612; USA;4CDMA; Pfizer Oncology; Shanghai200041; P. R. China;5USCACA; 939 S Highland Ave; Los Angeles; CA90036; USA.
..............page:505-506